- Home
- ABEV vs EW Comparison
ABEV vs EW Comparison
Compare ABEV & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEV | EW |
|---|---|---|
| Founded | 1885 | 1958 |
| Country | Brazil | United States |
| Employees | N/A | N/A |
| Industry | Beverages (Production/Distribution) | Industrial Specialties |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.8B | 49.9B |
| IPO Year | 2012 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ABEV | EW |
|---|---|---|
| Price | $3.14 | $89.68 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 4 | 21 |
| Target Price | $2.94 | ★ $96.37 |
| AVG Volume (30 Days) | ★ 27.9M | 4.9M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.66 |
| Revenue | N/A | ★ $6,067,600,000.00 |
| Revenue This Year | $7.96 | $13.39 |
| Revenue Next Year | $5.35 | $9.81 |
| P/E Ratio | ★ $16.99 | $131.74 |
| Revenue Growth | N/A | ★ 11.55 |
| 52 Week Low | $2.10 | $72.30 |
| 52 Week High | $3.45 | $89.60 |
Technical Indicators
Market Signals| Indicator | ABEV | EW |
|---|---|---|
| Relative Strength Index (RSI) | 47.59 | 60.83 |
| Support Level | $3.04 | $82.02 |
| Resistance Level | $3.23 | N/A |
| Average True Range (ATR) | 0.06 | 2.37 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 31.46 | 80.95 |
Price Performance
Historical ComparisonAbout ABEV Ambev S.A.
Ambev is the largest brewer in Latin America and the Caribbean and is Anheuser-Busch InBev's subsidiary in the region. It produces, distributes, and sells beer and PepsiCo products in Brazil and other Latin American countries and owns Argentina's largest brewer, Quinsa. Ambev was formed in 1999 through the merger of Brazil's two largest beverage companies, Brahma and Antarctica. In 2004, Ambev combined with Canadian brewer Labatt, giving AB InBev a controlling interest of 62%.
About EW Edwards Lifesciences Corporation
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.